University of Pittsburgh: Carcinoma trials

The registry lists 11 Carcinoma studies with University of Pittsburgh as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 1 3Phase 2 3No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically RemovedCompletedNCT00877071Phase 2Results posted
• Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell CarcinomaCompletedNCT00630409Phase 2Results posted
• Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCCTerminatedNCT00576056Phase 2Results posted
• Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck CancerCompletedNCT03268993Not applicable
• An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate RecurrenceCompletedNCT02296970
• Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related SymptomsCompletedNCT01640522Not applicable
• Comparison of Elective Lymph Node Treatment Versus Clinical Observation in the Absence of Palpable Lymph Nodes for High Risk Skin Squamous Cell Carcinoma (SCC)TerminatedNCT01252329Not applicable
• Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell CarcinomaTerminatedNCT01144169Phase 1
• Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell CarcinomaTerminatedNCT00903461Phase 1
• SBRT + TACE for Primary Hepatocellular CarcinomaWithdrawnNCT00746655Not applicable
• Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous TumorTerminatedNCT00377247Phase 1